-+ 0.00%
-+ 0.00%
-+ 0.00%

Lipocine Completes Scheduled Independent Data Safety Monitoring Board Review Of Ongoing Phase 3 Clinical Trial evaluating LPCN 1154 For Rapid Relief Treatment Of PPD.

Benzinga·01/12/2026 13:18:26
Listen to the news
  • Company on track to report topline results early in the second quarter of 2026
  • Second planned Data and Safety Monitoring Board (DSMB) meeting evaluated all available safety data for the 82 randomized
    • No drug discontinuations, excessive sedation, loss of consciousness, or drug-related SAEs reported
      • Study is no longer screening new participants